Review
Copyright ©The Author(s) 2020.
World J Gastroenterol. Mar 28, 2020; 26(12): 1231-1241
Published online Mar 28, 2020. doi: 10.3748/wjg.v26.i12.1231
Table 1 Age and venous thromboembolism risk
Ref.FindingsStatistics
Kappelman et al[19]IBD patients ≤ 20 are at increased risk of VTE compared to age and sex- matched non-IBD patientsHazard ratio 6.0 (95%CI: 2.5-14.7) for DVT Hazard ratio 6.4 (95%CI: 2.0-20.3) for PE
Annual incidence of VTE is higher in older patients than in younger patients with IBDAgeIncidence
≤ 20 yr8.9/10000 persons-years
> 60 yr54.6/10000 persons-years
Nylund et al[20]Hospitalized IBD children/adolescents are at increased risk of developing VTE compared to non-IBD hospitalized children/ adolescentsRelative risk 2.36 (95%CI: 2.15-2.58)
Odds of VTE increased as age increasedOdds ratio 2.32 (95%CI: 2.26-2.38)
Ando et al[22]IBD patients > 50 have an increased odds of developing VTEOdds ratio 3.52 (95%CI: 1.25-9.94)
Nguyen et al[5]Each incremental decade in age was associated with increased odds of developing VTEOdds ratio 1.20 (95%CI: 1.15-1.25)
Faye et al[23]Age > 30 had an increased risk of VTE readmission compared with patients younger than 18 years of ageAge (yr)Relative risk
31-402.10 (95%CI: 1.29-3.42)
41-502.08 (95%CI: 1.28-3.37)
51-653.74 (95%CI: 2.35-5.94)
66-804.04 (95%CI: 2.54-6.44)
> 803.06 (95%CI: 1.87-5.02)
McCurdy et al[24]IBD patients > 45 have an increased odds of developing VTE post-discharge3.76 odds ratio (95%CI: 1.80-7.89)
Table 2 Pregnancy and venous thromboembolism risk
Ref.FindingsStatistics
Hansen et al[29]Pregnant IBD patients are at increased risk of developing VTE as compared to pregnant non-IBD patientsRelative risk 1.67 (95%CI: 1.15-2.41)
Postpartum IBD patients are at a higher risk of developing VTE than postpartum non-IBD patientsRelative risk 2.10 (95%CI: 1.33-3.30)
Incidence of VTE is greatest in postpartum IBD womenGroupIncidence rate
Pregnant non-IBD2.41 (95%CI: 2.33-2.50)
Pregnant IBD4.20 (95%CI: 2.83-5.58)
Postpartum non-IBD2.88 (95%CI: 2.72-3.04)
Postpartum IBD7.03 (95%CI: 3.87-10.20)
Kim et al[30]Pregnant IBD patients are at increased risk of developing VTE as compared to non-IBD pregnant patientsRelative risk 2.13 (95%CI: 1.66-2.73)
Postpartum IBD patients are at increased risk of developing VTE as compared to postpartum non-IBD patientsRelative risk 2.61 (95%CI: 1.84-3.69)
UC patients are at an increased risk of developing VTE as compared to CD patients both during pregnancy and in postpartum periodGroupRelative risk
Pregnant UC vs CD patients2.24 (95%CI: 1.60-3.11)
Postpartum UC vs CD patients2.85 (95%CI: 1.79-4.52)
Table 3 Disease activity and venous thromboembolism risk
Ref.FindingsStatistics
Grainge et al[3]IBD flares are associated with increased risk of developing VTE as compared to non-IBD matched controlsHazard ratio 8.40 (95%CI: 5.50-12.80)
Hansen et al[29]IBD flare during pregnancy is associated with increased risk of developing VTE as compared to non-IBD pregnant patients (also compared to IBD pregnant patients without a flare)Unadjusted relative risk 2.64 (95%CI: 1.69-4.14)
Bollen et al[32]A significant proportion of patients had active disease at the time of VTE diagnosis60/84 (71%) patients with VTE had active disease
Table 4 Hospitalization and venous thromboembolism risk
Ref.FindingsStatistics
Grainge et al[3]Hospitalized IBD patients (regardless of disease activity) have an increased risk of VTEHazard ratio 2.10 (95%CI: 1.40-3.20)
Absolute risk of VTE in IBD patients is higher during hospitalized periods than during ambulatory periodsGroupAbsolute risk
Hospitalized25.2/1000 person-years
Ambulatory1.8/1000 person-years
Nguyen et al[5]Hospitalized IBD patients with VTE had greater mortality compared to those without VTEOdds ratio 2.50 (95%CI: 1.83-3.43)
Incidence of VTE in hospitalized IBD patients is increasingGroupPercent rise in odds
Hospitalized IBD17% rise over 7 yr
Hospitalized non-IBD14% rise over 7 yr
Kim et al[35]Hospitalized IBD patients without a disease flare had higher risk of VTE as compared to age- and sex-matched non-IBD patientsHazard ratio 12.97 (95%CI: 8.68-19.39)
Table 5 Medications and venous thromboembolism risk
MedicationsRisk of VTE
5-ASAPossible ↓
Corticosteroids↑↑↑
Azathioprine and 6-MercatopurinePossible ↓
TNFα inhibitors↓↓
Tofacitinib (10 mg twice a day)